Insights

Strategic Asset Expansion Immedica's recent acquisition of assets from Ovid Therapeutics, including future royalty rights and IP related to ganaxolone, presents opportunities for collaboration with healthcare providers and pharmaceutical partners interested in rare disease treatments and specialty care products.

Strong Industry Recognition Being recognized as a Great Place to Work for two consecutive years enhances Immedica’s attractiveness as a partner and employer, facilitating talent acquisition and fostering a positive corporate reputation in the pharmaceutical sector.

Leadership & Growth Strategic hires such as EVP Benjamin Owens and North America President Daniel Camardo demonstrate Immedica’s focus on expanding its market reach and strengthening its business development efforts, providing avenues for partnership in new territories and markets.

Investment Backing Immedica’s focus on rare diseases and specialty care, along with strategic partnerships and pipeline expansion including ultra-orphan drugs like Loargys, creates multiple entry points for sales channels targeting specialty pharmacy, healthcare providers, and niche treatment centers.

Similar companies to Immedica Pharma AB

Immedica Pharma AB Tech Stack

Immedica Pharma AB uses 8 technology products and services including Cloudflare CDN, RSS, Open Graph, and more. Explore Immedica Pharma AB's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • RSS
    Content Management System
  • Open Graph
    Content Management System
  • WordPress
    Content Management System
  • Salesforce
    Customer Relationship Management
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks
  • LiteSpeed
    Web Servers

Media & News

Immedica Pharma AB's Email Address Formats

Immedica Pharma AB uses at least 1 format(s):
Immedica Pharma AB Email FormatsExamplePercentage
First.Last@immedica.comJohn.Doe@immedica.com
50%
First.Last@immedica.comJohn.Doe@immedica.com
50%

Frequently Asked Questions

Where is Immedica Pharma AB's headquarters located?

Minus sign iconPlus sign icon
Immedica Pharma AB's main headquarters is located at 3 h Solnavägen Stockholm, Stockholm 113 63 Sweden. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Immedica Pharma AB's phone number?

Minus sign iconPlus sign icon
You can contact Immedica Pharma AB's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Immedica Pharma AB's official website and social media links?

Minus sign iconPlus sign icon
Immedica Pharma AB's official website is immedica.com and has social profiles on LinkedIn.

What is Immedica Pharma AB's NAICS code?

Minus sign iconPlus sign icon
Immedica Pharma AB's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Immedica Pharma AB have currently?

Minus sign iconPlus sign icon
As of February 2026, Immedica Pharma AB has approximately 164 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Cfo: S. F.Vice President Of Market Access: J. A.Head Of Global Partner Markets At Immedica: J. W.. Explore Immedica Pharma AB's employee directory with LeadIQ.

What industry does Immedica Pharma AB belong to?

Minus sign iconPlus sign icon
Immedica Pharma AB operates in the Pharmaceutical Manufacturing industry.

What technology does Immedica Pharma AB use?

Minus sign iconPlus sign icon
Immedica Pharma AB's tech stack includes Cloudflare CDNRSSOpen GraphWordPressSalesforceYoast SEOBootstrapLiteSpeed.

What is Immedica Pharma AB's email format?

Minus sign iconPlus sign icon
Immedica Pharma AB's email format typically follows the pattern of First.Last@immedica.com. Find more Immedica Pharma AB email formats with LeadIQ.

When was Immedica Pharma AB founded?

Minus sign iconPlus sign icon
Immedica Pharma AB was founded in 2018.

Immedica Pharma AB

Pharmaceutical ManufacturingStockholm, Sweden51-200 Employees

About Immedica Pharma
Immedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. 

Welcome to the Immedica social media channels 
The Immedica social channels are set up to share news, updates, and company happenings with all visitors. Please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy.
Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly.  
Examples of reasons for having a comment removed from a post on our social media might be:
- References a side effect or complaint
- Reporting of an adverse event, side effect or reaction from an Immedica product (that information should be reported directly to Immedica Drug Safety or to your physician.)
- A reference to a product or treatment
We work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice - your doctor or health care provider is the person to ask. 
If you have a product enquiry, please email the Immedica medical department.
- Abusive language
We welcome your feedback, provided that you share your view in a way that is respectful to our community, meaning not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products

Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.

Section iconCompany Overview

Headquarters
3 h Solnavägen Stockholm, Stockholm 113 63 Sweden
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    Immedica Pharma AB's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Immedica Pharma AB's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.